Graft versus leukemia.
作者信息
Butturini A, Gale R P
机构信息
Department of Pediatrics, University of Parma, Italy.
出版信息
Immunol Res. 1992;11(1):24-33. doi: 10.1007/BF02918605.
PMID:1602180
Abstract
摘要
相似文献
1
Graft versus leukemia.
Immunol Res. 1992;11(1):24-33. doi: 10.1007/BF02918605.
2
Graft-versus-leukaemia after bone marrow transplantation.
Pediatr Med Chir. 1991 Jan-Feb;13(1):9-13.
3
[Graft-versus-leukemia effect (GVL effect): pathophysiological and clinical aspects].
Nihon Rinsho. 1990 Sep;48(9):1977-82.
4
Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.
Semin Hematol. 1992 Jul;29(3 Suppl 2):46-52.
5
The graft versus leukemia effect: possible mechanisms and clinical significance to the biologic therapy of leukemia.
Bone Marrow Transplant. 1991;7 Suppl 1:33-7.
6
Critical issues in bone marrow transplantation immunology.
Bone Marrow Transplant. 1991;7 Suppl 1:24-5.
7
[Immunologic aspects of bone marrow transplantation].
Rev Fr Transfus Hemobiol. 1993 Jul;36(4):339-73. doi: 10.1016/s1140-4639(05)80239-4.
8
Bone marrow transplantation and graft-versus-host disease.
Curr Opin Immunol. 1989;2(6):870-5.
9
Induction of graft-versus-leukemia effect in a patient with chronic lymphocytic leukemia.
Bone Marrow Transplant. 1997 Jul;20(2):175-7. doi: 10.1038/sj.bmt.1700850.
10
[Antonio Raichs lecture. Graft versus host disease and the graft-against-leukemia reaction. Memorial lecture].
Sangre (Barc). 1990 Dec;35(6):465-73.
引用本文的文献
1
Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
Immunotherapy. 2009 Jul;1(4):599-621. doi: 10.2217/imt.09.32.
2
Chronic GvHD decreases antiviral immune responses in allogeneic BMT.
Blood. 2007 May 15;109(10):4548-56. doi: 10.1182/blood-2006-04-017442. Epub 2007 Feb 8.
本文引用的文献
1
Treatment of murine leukaemia with X rays and homologous bone marrow; preliminary communication.
Br Med J. 1956 Sep 15;2(4993):626-7. doi: 10.1136/bmj.2.4993.626.
2
3
A cloned human T cell line cytotoxic for autologous and allogeneic B lymphoma cells.
J Exp Med. 1984 Jul 1;160(1):239-54. doi: 10.1084/jem.160.1.239.
4
5
Lymphocyte cytotoxicity reactions to leukemia-associated antigens in identical twins.
Int J Cancer. 1972 May 15;9(3):648-58. doi: 10.1002/ijc.2910090323.
6
Immune reactivity of leukemia patients to autologous blast cells.
Cancer Res. 1972 Sep;32(9):1820-5.
7
Graft-versus-host disease.
Immunol Rev. 1985 Dec;88:193-214. doi: 10.1111/j.1600-065x.1985.tb01159.x.
8
Hyperacute graft-v-host disease in patients not given immunosuppression after allogeneic marrow transplantation.
Blood. 1986 Apr;67(4):1172-5.
9
Human tumor cell lines with pleiotropic drug resistance are efficiently killed by interleukin-2 activated killer cells and by activated monocytes.
Int J Cancer. 1987 Jul 15;40(1):104-7. doi: 10.1002/ijc.2910400119.
10
The role of T-cells in preventing relapse in chronic myelogenous leukemia.
Bone Marrow Transplant. 1987 Dec;2(4):351-4.
Zotero 插件